Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 1
1992 2
2010 1
2011 1
2012 1
2015 2
2016 2
2018 4
2019 1
2020 7
2021 10
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers for immunotherapy in urological cancers.
Gust KM, Resch I, D'Andrea D. Gust KM, et al. Among authors: resch i. Curr Opin Urol. 2018 Jan;28(1):25-28. doi: 10.1097/MOU.0000000000000465. Curr Opin Urol. 2018. PMID: 29120910 Review.
An update on systemic therapy for penile cancer.
Resch I, Abufaraj M, Hübner NA, Shariat SF. Resch I, et al. Curr Opin Urol. 2020 Mar;30(2):229-233. doi: 10.1097/MOU.0000000000000733. Curr Opin Urol. 2020. PMID: 31972637 Review.
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.
Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Laukhtina E, et al. Among authors: resch i. Crit Rev Oncol Hematol. 2022 Jan;169:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub 2021 Dec 10. Crit Rev Oncol Hematol. 2022. PMID: 34902554 Free article. Review.
35 results